Companies: 10,795·Total market cap: $144.5T
Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.

HTSUFOTCHealthcare
$29.00
+$0.00(+0.00%)
Market Cap$2.0B
P/E Ratio—
52W High$32.3
52W Low$28.94
Overview
股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Hisamitsu Pharmaceutical Co., Inc.（HTSUF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HTSUF · 截至 Jun 8, 2026

关键指标

EPS (TTM)$269.53htsuf eps ttm · htsuf earnings per shareEarnings history
PE Ratio (TTM)0.1×htsuf pe ratio ttm · htsuf price to earningsPE Ratio deep dive
Revenue (TTM)$163.1Bhtsuf revenue ttm · htsuf annual revenueFull revenue history
Dividend Yield2.84%does htsuf pay dividends · htsuf dividend yieldDividend history
Shares Outstanding71.3Mhtsuf shares outstanding · htsuf floatShares outstanding history
Next EarningsJul 9, 2026Est.htsuf earnings date · htsuf next earningsEarnings history

探索 Hisamitsu Pharmaceutical Co., Inc. 数据

htsuf stock data · financials
市值$2.0Bhtsuf market cap · htsuf valuation
分析师预测—
股息2.84%does hisamitsu pharmaceutical co., inc. pay dividends · htsuf dividend yield
营收$163.5B+4.80%hisamitsu pharmaceutical co., inc. annual revenue · htsuf revenue
盈利EPS $269.27-8.90%htsuf earnings · htsuf eps
市盈率0.1×htsuf pe ratio · htsuf price to earnings

财务快照

完整财报
FY 2026Revenue$163.49B▲ +4.80% YoY
202420252026
hisamitsu pharmaceutical co., inc. revenue · htsuf revenue 2026
FY 2026Net Income$19.22B▼ 11.68% YoY
202420252026
hisamitsu pharmaceutical co., inc. net income · htsuf profit 2026
FY 2026EPS$269.27▼ 8.90% YoY
202420252026
htsuf eps · hisamitsu pharmaceutical co., inc. earnings per share 2026
TTM:Revenue: $163.09BNet Income: $19.17BEPS: $269.53View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-10.22%
5Y-52.46%

关于 Hisamitsu Pharmaceutical Co., Inc.

CEOKazuhide Nakatomi
IPO DateSep 23, 2010
Employees2,759
CountryJP
Websitehisamitsu.co.jp

Hisamitsu Pharmaceutical Co., Inc. is a Japanese enterprise that develops and markets a range of pharmaceuticals, quasi-drugs, and medical devices. Its extensive product catalog includes popular exter…

Drug Manufacturers - Specialty & GenericHealthcareOTCJP

what is hisamitsu pharmaceutical co., inc. · htsuf stock overview · hisamitsu pharmaceutical co., inc. company profile · who is hisamitsu pharmaceutical co., inc. ceo · htsuf OTC · hisamitsu pharmaceutical co., inc. headquarters · hisamitsu pharmaceutical co., inc. business segments

关于股票概览与关键数据

Hisamitsu Pharmaceutical Co., Inc.（HTSUF）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Sep 23, 2010 在 OTC 上市。截至最近交易日，HTSUF 股价为 $29.00，市值约为 $2.0B。过去12个月累计回报 -10.22%，年初至今回报 +0.00%。

2026 财年 Hisamitsu Pharmaceutical Co., Inc. 营收 $163.5B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Hisamitsu Pharmaceutical Co., Inc.（HTSUF）股价为 $29.00，在 OTC 上市，52周区间为 $28.94 – $32.30。

HTSUF 最新股价HTSUF quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议